Literature DB >> 10155265

Economic incentives and disincentives for efficient prescribing.

B E Rittenhouse1.   

Abstract

Efficient prescribing is a controversial concept when defined in economic terms. Such terms imply that neither the best nor the cheapest drug may be efficient. Efficiency depends on patient evaluations of outcomes--an essential, yet still underdeveloped, field of inquiry. Encouraging prescribing efficiency (once it is clear what efficient treatments are) may require the use of incentives, (economic and otherwise). Although physicians do react to economic incentives, encouraging them to also act as good economists rather than only as good healthcare providers may be difficult since economic efficiency goals may conflict with pure medical goals. While it is conceptually reasonable to assume that economic incentives will accomplish behavioural change, other (noneconomic) incentive mechanisms may appear less controversial. Since it is the result, not the process, that is important, a mix of incentives to achieve efficient solutions is suggested. However, further investigation into both health and economic outcomes research and debate on proper efficiency goals should precede the discussion of optimal incentives.

Entities:  

Mesh:

Year:  1994        PMID: 10155265     DOI: 10.2165/00019053-199406030-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  29 in total

1.  Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.

Authors:  R J Lipsy
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

2.  Managing the physician: rules versus incentives.

Authors:  A L Hillman
Journal:  Health Aff (Millwood)       Date:  1991       Impact factor: 6.301

3.  Can managed care control costs?

Authors:  D W Moran; P R Wolfe
Journal:  Health Aff (Millwood)       Date:  1991       Impact factor: 6.301

4.  Economic and policy analysis of university-based drug "detailing".

Authors:  S B Soumerai; J Avorn
Journal:  Med Care       Date:  1986-04       Impact factor: 2.983

5.  Paying physicians in Canada: minding our Ps and Qs.

Authors:  J Lomas; C Fooks; T Rice; R J Labelle
Journal:  Health Aff (Millwood)       Date:  1989       Impact factor: 6.301

6.  Doctors and the dispensing of drugs.

Authors:  A S Relman
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

7.  Financial incentives for physicians in HMOs. Is there a conflict of interest?

Authors:  A L Hillman
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

8.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

Authors:  J Avorn; S B Soumerai
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

9.  The distinction between cost and charges.

Authors:  S A Finkler
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

10.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.